Klebsiella pneumoniae K2 capsular polysaccharide degradation by a bacteriophage depolymerase does not require trimer

Ting-Juan Ye1, Kit-Man Fung1, I-Ming Lee2

  • 1Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.

Mbio
|February 13, 2024
PubMed

Insights

A novel phage tailspike protein, K2-2, depolymerizes K2 capsular polysaccharide from Klebsiella pneumoniae, retaining O-acetylation crucial for vaccine development. Trimer formation is not required for its catalytic activity.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Hypervirulent Klebsiella pneumoniae infections pose a significant threat.
  • Generating immunogenic capsular polysaccharide fragments for vaccines is challenging.
  • The role of the C-terminal region in phage tailspike protein (TSP) folding and trimerization is poorly understood.

Purpose of the Study:

  • To characterize a phage tailspike protein (K2-2) that depolymerizes K2 capsular polysaccharide (CPS) from K. pneumoniae.
  • To elucidate the structure and catalytic mechanism of K2-2.
  • To investigate the role of trimerization in TSP activity and its implications for vaccine development.

Main Methods:

  • Structural elucidation of the K2-2 enzyme in trimeric and tetrameric forms.
  • Site-directed mutagenesis to identify catalytic residues and assess functional impact.
  • Biophysical and functional characterization of enzyme activity.
  • Analysis of O-acetylation on depolymerized CPS fragments.

Main Results:

  • K2-2 specifically depolymerizes K2 CPS into tetrasaccharide units, preserving O-acetylation.
  • Structural analysis revealed intersubunit carbohydrate-binding grooves accommodating CPS fragments.
  • Catalytic activity was confirmed to be independent of trimer formation, with a single mutation disrupting trimerization.
  • Mutant enzyme efficacy against K2 K. pneumoniae was assessed.

Conclusions:

  • The K2-2 enzyme provides a novel tool for generating vaccine-relevant CPS fragments.
  • The findings challenge the paradigm of trimer-dependent TSP activity.
  • Understanding K2-2's catalytic mechanism offers insights for designing anti-K. pneumoniae glycoconjugate vaccines.

Related Concept Videos

Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.2K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
835